4.7 Editorial Material

Genomic Analyses and Precision Oncology in Gastroesophageal Cancer : Forwards or Backwards?

Journal

CANCER DISCOVERY
Volume 8, Issue 1, Pages 14-16

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-17-1295

Keywords

-

Categories

Funding

  1. National Medical Research Council (NMRC) MOH Healthcare Research Scholarship, Singapore
  2. Duke-NUS Medical School
  3. Biomedical Research Council, Agency for Science, Technology and Research

Ask authors/readers for more resources

Gastroesophageal adenocarcinoma (GEA) comprises a myriad of distinct subtypes with significant interpatient, intrapatient, and intratumor heterogeneity. Strategies for tackling molecular heterogeneity will be essential for the success of GEA precision oncology-in this regard, blood-based liquid biopsies may provide broader views of the real-time genomic landscape of this disease, identifying actionable biomarkers and monitoring therapy resistance. (C) 2018 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available